This is an important follow-up to my March 18, 2020, COVID-19 related article on Athersys Inc. (ATHX) that discussed the company's ongoing discussions with the Biomedical Advanced Research and Development Authority (BARDA) to bring an experimental treatment to COVID-19 patients suffering from the highly deadly condition known as Acute Respiratory Distress Syndrome (ARDS). Those who have not read that article should do so before continuing.
Source Live Science.com
Last night, Athersys partner and major shareholder, Healios KK, exercised its warrant for 4,000,000 shares ahead of the warrant's expiration date of 9/1/20:
CLEVELAND--(BUSINESS